Letter by Pericas et al Regarding Article, “Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Amat-Santos et al1 assessed the incidence, clinical features, and outcomes of infective endocarditis (IE) during the first year after transcatheter aortic valve replacement (TAVR). The incidence of IE reported was lower than in the largest recent studies, including that of our group.2,3
Also significant was the lower rate of periannular complications. Abscesses, fistulas, and pseudoaneurysms were more common in the study performed by our group (45% versus 22.7%).2 In addition, only 4 patients (7.5%) with IE underwent valve surgery with no impact on outcomes1; we found that 32% of patients had undergone surgery.2 Although this finding could be due to publication bias, a relevant point we covered that is not addressed by Amat-Santos et al1 is the question of whether patients with heart failure should undergo surgery. In our study, only 1 of the 18 heart failure–free patients …